Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micol Romano

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Pediatrics|October 6, 2022
Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic ArthritisAdele Civino, Francesca Bovis, Marta Ponzano, et al.
European Journal of Immunology|April 22, 2023
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patientsAnna Vanni, Alessio Mazzoni, Roberto Semeraro, et al.
Seminars in Arthritis and Rheumatism|June 28, 2021
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest groupMelissa Oliver, Aruni Jayatilleke, Eveline Wu, et al.
The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.
Seminars in Arthritis and Rheumatism|November 21, 2025
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working groupMelissa Oliver, Farzana Nuruzzaman, Aleksander Lenert, et al.
Annals of the Rheumatic Diseases|May 27, 2022
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonistMicol Romano, Z Serap Arici, David Piskin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2022
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor AntagonistMicol Romano, Z Serap Arici, David Piskin, et al.
Annals of the Rheumatic Diseases|July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Pediatrics|October 6, 2022
Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic ArthritisAdele Civino, Francesca Bovis, Marta Ponzano, et al.
European Journal of Immunology|April 22, 2023
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patientsAnna Vanni, Alessio Mazzoni, Roberto Semeraro, et al.
Seminars in Arthritis and Rheumatism|June 28, 2021
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest groupMelissa Oliver, Aruni Jayatilleke, Eveline Wu, et al.
The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.
Seminars in Arthritis and Rheumatism|November 21, 2025
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working groupMelissa Oliver, Farzana Nuruzzaman, Aleksander Lenert, et al.
Annals of the Rheumatic Diseases|May 27, 2022
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonistMicol Romano, Z Serap Arici, David Piskin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2022
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor AntagonistMicol Romano, Z Serap Arici, David Piskin, et al.
Annals of the Rheumatic Diseases|July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGSKader Cetin Gedik, Lovro Lamot, Micol Romano, et al.
Pageof 5